SLC7A11 and cancer: Additionally, we confirmed the downregulation of SLC7A11 mRNA in viable cancer cells with SNF2L deletion (Fig. 4J), whereas SLC7A11 mRNA was elevated in HCCLM3 cells overexpressing SNF2L (Fig. 4K).